Condition
Colorectal Cancer (Locally Advanced or Metastatic)
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 4 (1)
Trial Status
Not Yet Recruiting2
Active Not Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07457541Phase 1Active Not Recruiting
Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI
NCT07446465Phase 4Not Yet RecruitingPrimary
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
NCT07410494Phase 1Recruiting
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
NCT07260058Phase 1Not Yet Recruiting
Immune Cell Therapy for Advanced Solid Tumors
Showing all 4 trials